13F-HR filed by SECTOR GAMMA AS
SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-12, with 31 holding rows worth $412,484,876.
- Accession
- 0000945621-23-000266
- Filer
- CIK 1475373
- Filed
- 2023-05-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 31 entries on the cover page, a total value of $412,484,876 stated on the cover page (in dollars after the unit check, H1), rows summing to $412,484,876 with VALUE read as dollars as filed, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Gilead Sciences,Inc. | 375558103 | COM | 542,773 | $45,033,876 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 432,235 | $31,237,623 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 449,571 | $31,159,766 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 376,701 | $28,440,926 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 318,904 | $25,710,040 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 87,836 | $24,421,043 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 176,103 | $22,752,508 | dollars as filed | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 81,415 | $18,678,229 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 35,779 | $16,451,542 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 156,350 | $15,203,474 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 238,746 | $15,091,135 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 158,806 | $13,138,020 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 153,117 | $12,071,744 | dollars as filed | |
| QIAGEN NV | N72482123 | SHS NEW | 260,787 | $11,977,947 | dollars as filed | |
| CATALENT INC USD 0.01 | 148806102 | COM | 150,501 | $9,889,421 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 165,227 | $9,817,788 | dollars as filed | |
| NUVASIVE INC | 670704105 | COM | 233,756 | $9,656,460 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 162,397 | $8,124,722 | dollars as filed | |
| SEAGEN INC | 81181C104 | COM | 36,000 | $7,288,920 | dollars as filed | |
| BAXTER INTL INC | 071813109 | COM | 167,000 | $6,773,520 | dollars as filed | |
| BIO RAD LABS INC | 090572207 | CL A | 13,617 | $6,522,815 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 56,153 | $5,974,118 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 23,677 | $5,506,086 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 27,389 | $5,486,564 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 146,441 | $5,233,801 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 232,718 | $4,379,753 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 106,282 | $4,261,908 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 145,545 | $3,386,832 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 26,554 | $3,307,832 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 38,310 | $2,846,816 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 54,906 | $2,659,647 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000945621-23-000266 | this filing | 2023-05-12 | acceptance time not in the bulk data set |